Ted Slafsky

University White Paper on 340B Says Pharma and Hospitals Will Keep Testing 340B’s Bounds Until Congress Acts

In Research/ReportsOctober 19, 2021178 Views

Pharma and hospitals will keep testing the bounds of the 340B program until Congress steps in, a University of Southern California (USC) health policy research fellow predicts in a new white paper.

Drug manufacturers and hospitals “will likely continue to test the bounds” of the 340B program until Congress passes legislation addressing multiple concerns about it, a University of Southern California (USC) health policy research fellow says in a new white paper.

…

News Alert: New Senate Bill Would Let HRSA Audit 340B Providers to See How They Use 340B Net Income

In Federal, LegislativeSeptember 24, 20211395 Views

Tom Mirga and Ted Slafsky

Senator Mike Braun (R-IN) has introduced legislation to let the government audit 340B entities to determine how they use net income from 340B savings.

U.S. Sen. Mike Braun (R-Ind.) introduced legislation last night to let the federal government audit 340B covered entities to determine how they use net income from drugs bought under the 340B program.

Please Login or Become

…

U.S. Supreme Court Schedules Oral Arguments on 340B Reimbursement Case

In UncategorizedSeptember 21, 2021504 Views

Ron Shinkman and Ted Slafsky

The Supreme Court’s decision to hear the case over Medicare-related 340B cuts to hospitals surprised many observers. Oral arguments are scheduled for Nov. 30, with a decision not likely until the spring.

The U.S. Supreme Court has announced the cases it will take up this fall and 340B will be on the plate. The court recently posted its hearings schedule for the months of October through December and will hear oral

…

House GOP Conference Chair Stefanik Signs on to 340B Anti-Pickpocketing Bill

In UncategorizedSeptember 21, 2021348 Views

Tom Mirga and Ted Slafsky

House Republican conference chair Elise Stefanik (R-NY) is the most high profile sponsor of date for the bipartisan 340B Protect Act.

U.S. House GOP Conference Chair Elise Stefanik (N.Y.), the third highest-ranking House Republican, has issued a news release and tweeted about signing on as a sponsor of bipartisan legislation prohibiting pharmacy benefit managers (PBMs) and other third-party payers from paying

…

Biden Picks Academic with Hospital Connections to Run HHS Policy Shop

In UncategorizedSeptember 21, 2021106 Views

Tom Mirga and Ted Slafsky

Robert Otto Valdez has been selected by President Biden for a key HHS policy position that impacts the 340B program.

President Biden announced last week that he plans to nominate public health expert Robert Otto Valdez to serve as U.S. Health and Human Services (HHS) Assistant Secretary for Planning and Evaluation (ASPE).

Please Login or Become

…

News Alert: Key House Committee Excludes “Spread Pricing” Language that 340B Entities Feared from Drug Pricing Legislation

In Federal, LegislativeSeptember 10, 2021644 Views

Tom Mirga and Ted Slafsky

The House Energy & Commerce Committee excluded spread-pricing language that 340B entities feared from forthcoming drug pricing legislation.

340B covered entities are breathing easier today upon learning that U.S. House Democrats excluded much-feared Medicaid managed care “spread pricing” language from forthcoming drug pricing legislation.

Please Login or Become a Paid Subscriber to View this

…

HRSA Veteran Herzog to Oversee 340B Program as Agency Begins Search for New OPA Director

In Federal, RegulatoryAugust 31, 2021515 Views

Tom Mirga and Ted Slafsky

Michelle Herzog, the new acting director of HRSA's 340B drug pricing program, speaks at the 2015 340B Coalition summer conference.

Michelle Herzog, long-time second-in-command at the U.S Health Resources and Services Administration’s Office of Pharmacy Affairs (OPA), has taken charge as OPA director on an acting basis.

Please Login or Become a Paid Subscriber to View

…

Young Firebrand Lawmaker Gets into Shouting Match with 340B Champion

In Federal, LegislativeAugust 3, 2021342 Views

Ted Slafsky

U.S. Rep. Madison Cawthorn (R-N.C., left) and the staff of Rep. David McKinley (R-W.Va., right) allegedly got into "a back-and-forth" last week over Cawthorn's listing as a co-sponsor of 340B legislation that McKinley filed with Rep. Abigail Spanberger (D-Va.).

News organization Politico reports that U.S. Rep. Madison Cawthorn (R-N.C.) “got into a back-and-forth with” the staff of Rep. David McKinley (R-W.Va.) last week Thursday, July 29, over Cawthorn’s listing as a co-sponsor of legislation to protect 340B covered

…

News Alert: Bipartisan Bill Introduced to Protect 340B Providers From Reimbursement Cuts and Address Duplicate Discount Challenge

In Federal, LegislativeJuly 9, 20211052 Views

Ted Slafsky

Reps. David McKinley (R-WV) and Abigail Spanberger (D-VA) introduced legislation today to address so called pickpocketing of 340B provider savings and establish a clearinghouse to address duplicate discounts.

Reps. David McKinley (R-WV) and Abigail Spanberger (D-VA) introduced the PROTECT 340B Act today, which would prohibit pharmacy benefit managers (PBMs) and other third-party payers from paying 340B providers below-market rates or engaging in other perceived discriminatory contracting practices. While …

Two High Profile Opioid Makers Among Companies Announcing Refunds to 340B Providers But Refunds for Mallinckrodt’s Top-Selling Drug Remain Elusive

In Judicial, Pharma IndustryJuly 8, 2021176 Views

Ted Slafsky

Refunds for Mallinckrodt’s top-selling drug is noticeably absent from recent posting.

For the fourth time since 2020, Purdue Pharma has announced refunds to 340B covered entities for overcharges. Purdue, which pled guilty in November in federal court to fraud and kickback charges related to its role in fueling the national opioid-abuse …